Myeloma

>

CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.

Latest News

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status: © stock.adobe.com.
FDA Grants Orphan Drug Status to SAR446523 for Relapsed Myeloma

July 31st 2025

SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for relapsed/refractory multiple myeloma.

Image of FDA sign.
FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma

July 18th 2025

The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.
FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma

July 2nd 2025

Image of FDA text.
FDA Approves CAR T Therapy Label Updates Across Various Blood Cancers

June 27th 2025

Image of ronald.
Traveling with Multiple Myeloma: A Journey of Adaptation and Hope

June 25th 2025

Multiple Myeloma Diagnosis: The Beginning of Beth’s Story

Elie Fahed, MD, provides an overview of what multiple myeloma is, and Beth walks us through her frustrating journey to initial diagnosis as an atypical patient.

Multiple Myeloma Diagnosis: The Beginning of Beth’s Story

More News